Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)-Reference-Cited by-同舟云学术

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)

Published:2015-09-30 Issue:2 Volume:125 Page:359-367
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Lombardi Giuseppe,Pace Andrea,Pasqualetti Francesco,Rizzato Simona,Faedi Marina,Anghileri Elena,Nicolotto Elisa,Bazzoli Elena,Bellu Luisa,Villani Veronica,Fabi Alessandra,Ferrazza Patrizia,Gurrieri Lorena,Dall’Agata Monia,Eoli Marica,Della Puppa Alessandro,Pambuku Ardi,D’Avella Domenico,Berti Franco,Rudà Roberta,Zagonel Vittorina

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-015-1923-x.pdf

Reference27 articles.

1. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 16 Suppl 4:iv1-63. doi: 10.1093/neuonc/nou223

2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi: 10.1056/NEJMoa043330

3. Laperriere N, Weller M, Stupp R, Perry JR, Brandes AA, Wick W, van den Bent MJ (2013) Optimal management of elderly patients with glioblastoma. Cancer Treat Rev 39:350–357. doi: 10.1016/j.ctrv.2012.05.008

4. Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227–235. doi: 10.1215/S1152851703000620

5. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707–715. doi: 10.1016/S1470-2045(12)70164-X

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent chemoradiation therapy for improving survival in older patients with glioblastoma: a narrative review;Journal of Korean Society of Geriatric Neurosurgery;2024-06-30

2. Untangling the web of glioblastoma treatment resistance using a multi-omic and multidisciplinary approach;The American Journal of the Medical Sciences;2023-09

3. The impact of survivorship bias in glioblastoma research;Critical Reviews in Oncology/Hematology;2023-08

4. Patterns of failure in glioblastoma multiforme following Standard (60 Gy) or Short course (40 Gy) radiation and concurrent temozolomide;Japanese Journal of Radiology;2023-01-17

5. Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy;La radiologia medica;2022-07-18